Number of the records: 1
Novel nanoparticle delivery systems for rifampicin: an effective strategy against tuberculosis?
- 1.
SYSNO ASEP 0475342 Document Type J - Journal Article R&D Document Type O - Ostatní Subsidiary J Článek ve WOS Title Novel nanoparticle delivery systems for rifampicin: an effective strategy against tuberculosis? Author(s) Trousil, Jiří (UMCH-V) RID, ORCID
Hrubý, Martin (UMCH-V) RID, ORCIDSource Title Nanomedicine. - : Future Medicine - ISSN 1743-5889
Roč. 12, č. 12 (2017), s. 1359-1361Number of pages 3 s. Language eng - English Country GB - United Kingdom Keywords nanoparticles ; rifampicin ; tuberculosis Subject RIV CD - Macromolecular Chemistry OECD category Polymer science R&D Projects LO1507 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Method of publishing Limited access Institutional support UMCH-V - RVO:61389013 UT WOS 000403575000002 EID SCOPUS 85020930556 DOI 10.2217/nnm-2017-0117 Annotation Tuberculosis (TB) is a highly infectious disease caused by Mycobacterium tuberculosis. Approximately, a third of the world’s population is infected with M. tuberculosis, resulting in a global health problem. Although potentially curative treatments have been available for approximately 50 years, TB remains the leading cause of preventable death in the world. Workplace Institute of Macromolecular Chemistry Contact Eva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358 Year of Publishing 2018
Number of the records: 1